![Acetaminophen recall: Incorrect dosage on label could lead to overdose, Health Canada says | CTV News Acetaminophen recall: Incorrect dosage on label could lead to overdose, Health Canada says | CTV News](https://www.ctvnews.ca/polopoly_fs/1.5615061.1633625370!/httpImage/image.jpeg_gen/derivatives/landscape_1020/image.jpeg)
Acetaminophen recall: Incorrect dosage on label could lead to overdose, Health Canada says | CTV News
![Teva Canada Announces New Autoinjector for AJOVY® for the Preventive Treatment of Migraine in Adults | BioSpace Teva Canada Announces New Autoinjector for AJOVY® for the Preventive Treatment of Migraine in Adults | BioSpace](https://mms.businesswire.com/media/20210408005437/en/868792/4/Teva_Canada_-_AJOVY_Autoinjector.jpg)
Teva Canada Announces New Autoinjector for AJOVY® for the Preventive Treatment of Migraine in Adults | BioSpace
Teva Pharmaceutical Industries Ltd. - On Thursday May 12, Doug Sommerville General Manager Teva Canada, John Jacobs GM for Teva Canada Innovation, Ben Gray VP, General Counsel, Bennett Lee and Houri Ohan
![Teva Canada Announces the Launch of <C>ACT Methylphenidate ER® Tablets, a Generic Version of <C>Concerta® for the Treatment of ADHD | Markets Insider Teva Canada Announces the Launch of <C>ACT Methylphenidate ER® Tablets, a Generic Version of <C>Concerta® for the Treatment of ADHD | Markets Insider](https://mma.prnewswire.com/media/657121/Teva_Canada_Limited_Teva_Canada_Announces_the_Launch_of__ACT_M.jpg)
Teva Canada Announces the Launch of <C>ACT Methylphenidate ER® Tablets, a Generic Version of <C>Concerta® for the Treatment of ADHD | Markets Insider
![Teva Pharmaceuticals and State Responsible for Opioid Epidemic in NY, Jury Finds - Top Class Actions Teva Pharmaceuticals and State Responsible for Opioid Epidemic in NY, Jury Finds - Top Class Actions](https://s40123.pcdn.co/wp-content/uploads/2022/01/shutterstock_1424969885.jpg.optimal.jpg)
Teva Pharmaceuticals and State Responsible for Opioid Epidemic in NY, Jury Finds - Top Class Actions
![Teva Canada Announces Availability of Aermony RespiClick™, an Innovative New Device for the Treatment of Bronchial Asthma | BioSpace Teva Canada Announces Availability of Aermony RespiClick™, an Innovative New Device for the Treatment of Bronchial Asthma | BioSpace](https://mms.businesswire.com/media/20201005005212/en/826961/4/AermonyRespiClick_ENG.jpg)
Teva Canada Announces Availability of Aermony RespiClick™, an Innovative New Device for the Treatment of Bronchial Asthma | BioSpace
![Teva Canada Announces the Launch of AJOVY™ For the Preventive Treatment of Migraine in Adults Who Have at Least Four Migraine Days Per Month | Business Wire Teva Canada Announces the Launch of AJOVY™ For the Preventive Treatment of Migraine in Adults Who Have at Least Four Migraine Days Per Month | Business Wire](https://mms.businesswire.com/media/20200429005090/en/713670/23/teva_RGB_JPEG.jpg)